Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2012
10/31/2012EP2517730A2 Vitamin receptor binding drug delivery conjugates
10/31/2012EP2517729A2 Vitamin receptor binding drug delivery conjugates
10/31/2012EP2517726A2 Lentivirus vaccine based on the recombinant viral vaccine against yellow fever
10/31/2012EP2517725A1 Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease
10/31/2012EP2517724A1 Adhesin-enterotoxin chimera based immunogenic composition against entertoxigenic escherichia coli
10/31/2012EP2517723A1 Compositions and methods of enhancing immune responses
10/31/2012EP2516649A2 Novel pneumovirus compositions and methods for using the same
10/31/2012EP2516629A2 Herpes simplex virus vaccines
10/31/2012EP2516470A1 Antibodies to non-functional oligomeric p2x7 receptors
10/31/2012EP2516469A1 Anti-her3 antibodies and uses thereof
10/31/2012EP2516468A1 Anti-flt3 antibodies and methods of using the same
10/31/2012EP2516467A2 Compositions comprising tnf-alpha and il-6 antagonists and methods of use thereof
10/31/2012EP2516465A1 Anti-bv8 antibodies and uses thereof
10/31/2012EP2516458A1 Tetravalent cd47-antibody constant region fusion protein for use in therapy
10/31/2012EP2515941A1 Antibody formulation
10/31/2012EP2515940A1 Immunogenic compositions and related methods
10/31/2012EP2515939A1 Photo-inactivated viruses and systems and methods of using the same
10/31/2012EP2515938A1 Immunogenic compositions
10/31/2012EP2515937A1 Non-fermented compositions comprising a cereal based fraction and a probiotic and uses thereof
10/31/2012EP2515936A1 Streptavidin and biotin- based antigen delivery system
10/31/2012EP2515935A1 A method of treating a staphylococcus infection in a patient having a low-level pathogenic pseudomonas aeruginosa infection
10/31/2012EP2515934A2 Vaccine compositions
10/31/2012EP2515933A1 Receptors of rspo2 and rspo3
10/31/2012EP2515661A1 Immunoprotection by oral administration of recombinant lactococcus lactis mini-capsules
10/31/2012CN1835977B CD20-binding polypeptide compositions
10/31/2012CN1612750B TACI-immunoglobulin fusion proteins
10/31/2012CN102762595A Antibodies to non-functional oligomeric p2x7 receptors
10/31/2012CN102762593A Fully human antibodies to btla
10/31/2012CN102762588A Anti-trypanosome therapeutic and diagnostic applications
10/31/2012CN102762228A Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
10/31/2012CN102762227A Endoglin antibodies
10/31/2012CN102762226A Benzonaphthyridine-containing vaccines
10/31/2012CN102762225A Peptides for vaccines against birch allergy
10/31/2012CN102762224A Vaccine compositions
10/31/2012CN102757942A Recombinant vaccine strain for foot-and-mouth disease type A as well as preparation method thereof and application thereof
10/31/2012CN102757941A Hepatitis A virus strain HAV-ZL2012, vaccine prepared by using same and application thereof
10/31/2012CN102757940A Duck flavivirus and preparation and application of inactivated vaccine of duck flavivirus
10/31/2012CN102757499A Antibody for resisting osteopontin chimerism, preparation method and application thereof in preparation of drugs for treating osteoporosis
10/31/2012CN102757498A Bifunctional antibody for resisting four serotype dengue viruses and application thereof in preparation of drugs for resisting dengue virus infection
10/31/2012CN102757497A Anti-PEDF monoclonal antibody, and preparation method and application thereof
10/31/2012CN102757495A Holistic anti-VEGF antibody, preparation method and application thereof
10/31/2012CN102757492A Holistic hepatitis B surface protein monoclonal antibodies and application thereof to preparation of medicines for preventing HBV (hepatitis B virus) infection
10/31/2012CN102757484A HCV (hepatitis C virus) poly-epitope peptide vaccine and application thereof
10/31/2012CN102757483A Recombinant adenovirus for expressing porcine teschovirus type 8 VP1 protein and application thereof
10/31/2012CN102757481A Function epitopes of staphylococcal enterotoxin B (SEB), monoclonal antibodies specifically bound with function epitopes and application of monoclonal antibodies
10/31/2012CN102757480A Anti-dengue virus type-4 neutralizing epitope-specific antibody and application of anti-dengue virus type-4 neutralizing epitope-specific antibody to treatment of dengue virus type-4 infection
10/31/2012CN102755652A Bivalent DNA (Deoxyribonucleic Acid) vaccine and preparation method thereof
10/31/2012CN102755646A Medicament for treating TNF alpha related disorder
10/31/2012CN102755645A Influenza vaccines with reduced amount of emulsion adjuvant
10/31/2012CN102755644A Rabbit haemorrhagic disease tissue inactivated vaccine and preparation method thereof
10/31/2012CN102755643A Meningococcus anti-idiotypic antibody vaccine
10/31/2012CN102755642A Preparing method of anthrax vaccines
10/31/2012CN102755631A Novel immunogenic compositions for the prevention and treatment of meningococcal disease
10/31/2012CN102091027B Method for preparing antitumor small interfering RNA carrying magnetic nano probe
10/31/2012CN101972478B 抗体治疗 Antibody therapy
10/31/2012CN101687925B Engineered anti-IL-23p19 antibodies
10/31/2012CN101563365B Anti-IL-6 monoclonal antibodies and uses thereof
10/31/2012CN101365486B Combination therapy using anti-EGFR and anti-HER2 antibodies
10/31/2012CN101262884B Anti A beta antibody formulation
10/31/2012CN101208104B Nipah virus vaccines
10/31/2012CN101141980B Antibodies against human interleukin-13 and uses therefor
10/31/2012CN101112390B Joint production method for distilling immunopotentiator from waste blood
10/31/2012CN101107269B Monoclonal antibodies against NKG2A
10/31/2012CN101035808B Humanized anti-CMET antagonists
10/30/2012US8299232 Constructing a DNA chimera for vaccine development against leishmaniasis and tuberculosis
10/30/2012US8299229 Mucin antigen vaccine
10/30/2012US8299222 Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
10/30/2012US8299221 LINGO binding molecules and pharmaceutical use thereof
10/30/2012US8299213 Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses
10/30/2012US8299031 Human semen enhancer of viral infection peptides (SEVI) and their use
10/30/2012US8298820 Influenza nucleic acid molecules and vaccines made therefrom
10/30/2012US8298805 Signal for packaging of influenza virus vectors
10/30/2012US8298771 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
10/30/2012US8298769 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
10/30/2012US8298552 Attenuated Mycoplasma gallisepticum strains
10/30/2012US8298551 Streptococcus pyogenes antigens and corresponding DNA fragments
10/30/2012US8298550 PEGylated mutated Clostridium botulinum toxin
10/30/2012US8298549 Sequential administration of a replication defective adenovirus vector in vaccination protocols
10/30/2012US8298547 IgE CH3 peptide vaccine
10/30/2012US8298546 Isolation and purification of P. falciparum merozoite protein-142 vaccine
10/30/2012US8298545 Anti-autoimmune antibodies for treatment of pemphigus
10/30/2012US8298544 CEACAM based antibacterial agents
10/30/2012US8298543 Identification and application of antibiotic synergy
10/30/2012US8298542 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia
10/30/2012US8298541 Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae
10/30/2012US8298540 Methods of modulating T cell-mediated immune responses with anti-P-selectin glycoprotein ligand 1 antibodies
10/30/2012US8298539 Human cytomegalovirus neutralizing antibodies and use thereof
10/30/2012US8298538 Human cytomegalovirus neutralising antibodies and use thereof
10/30/2012US8298537 Concomitant treatment of rheumatoid arthritis with anti-TNF-α antibodies and methotrexate
10/30/2012US8298536 Methods of treating inflammatory pain
10/30/2012US8298535 Anti-IL-7 receptor antibodies
10/30/2012US8298534 Method of treating fibrproliferative disorders
10/30/2012US8298533 Antibodies to IL-1R1
10/30/2012US8298532 Fusion polypeptides capable of activating receptors
10/30/2012US8298531 Treatment with anti-alpha2 integrin antibodies
10/30/2012US8298530 Stable lyophilized pharmaceutical formulation of IgG antibodies
10/30/2012US8298525 Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist
10/30/2012US8298522 Methods of modulating MUC1 expression to inhibit inflammation
10/30/2012CA2705869C Poxviral oncolytic vectors
10/30/2012CA2683318C Diazo bicyclic smac mimetics and the uses thereof
1 ... 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 ... 1823